Another Vaping Illness Study Withdrawn


by Vaping Daily Team

Updated: July 28, 2023

Another Vaping Illness Study Withdrawn

Explore the issues surrounding the retraction of a study that linked vaping to liver disease due to invalid claims and methodology. This article delves into the wider problem of flawed e-cigarette research, highlighting the need for more stringent scientific standards and unbiased reporting in the field

The Controversial Study and its Retraction

A research paper suggesting a connection between vaping and liver disease has been withdrawn when the authors couldn’t substantiate their assertions. The study, named “Association of Smoking and E-Cigarette in Chronic Liver Disease: An NHANES Study”, used the National Health and Nutrition Examination Survey (NHANES) data from 2015-2018 to examine a potential correlation between vaping and liver disease. Published in Gastroenterology Research in June 2022, it suggested higher odds of liver disease even among infrequent vapers. However, one year later, the study was retracted due to doubts about its methodology, data processing, and the credibility of its conclusions. The authors were offered an opportunity to address these concerns, but were unable to do so, leading to the formal retraction by the journal’s editor-in-chief, Robert Wong.

Addressing the Flawed Vaping Studies

Renowned tobacco harm reduction researchers Riccardo Polosa, founder of CoEHAR, and Konstantinos Farsalinos, a research fellow at the Onassis Cardiac Surgery Center in Athens, have previously emphasized that numerous substandard vape studies are skewing the scientific narrative. In the article “A tale of flawed e-cigarette research undetected by defective peer review process”, which was featured in Internal and Emergency Medicine, Polosa and Farsalinos critically examined and highlighted common errors often found in studies that push an anti-vaping narrative. They stressed the importance of considering the timing of events in determining correlations, an element often overlooked by studies and editorial teams of esteemed scientific journals.

Highlighting Methodological Flaws in Top Cited E-Cigarette Research

Furthermore, an international team of researchers led by Dr. Cother Hajat of the (UAEU) and Prof. Riccardo Polosa discovered that almost all of the top 24 most frequently quoted vaping studies, published in esteemed medical journals, have methodological issues. Their analysis titled, “Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research,” revealed a host of fatal flaws in these studies. The review pointed out several inadequacies such as studies lacking a clear hypothesis statement, poor identification of main outcome measures, and failure to control for confounding factors. These flaws were especially apparent concerning the Gateway Theory, where results and discussions contained numerous unsubstantiated claims due to improper methods. Many researchers purported to discover causal relationships without backing them up with significant data, making the discussions and conclusions of these studies misleading.

Concluding Thoughts

In conclusion, the phenomenon of flawed vaping studies, as demonstrated by the retraction of the liver disease study, calls for stricter scientific scrutiny and regulation in e-cigarette research. The prevalent methodological shortcomings have not only skewed the narrative surrounding vaping but have also contributed to misinformation. It is paramount that future research ensures rigorous methodology and unbiased presentation of data. In this rapidly evolving field, it is crucial that public health decisions are grounded in high-quality, reliable scientific evidence, free from any form of methodological flaws or biased interpretations.

Published: July 28, 2023

Vaping Daily Team

The Vaping Daily team is a collective of expert vapers. We tried hundreds of vapes and happily review them here. Our guides, reviews, and top lists share the best practices from our experience . Subscribe to e-mails to get vape news and deals.